United States Human Rabies Immunoglobulin (IM) Market Report 2016

December 2016 | 113 pages | ID: U78BEB05B39EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Human Rabies Immunoglobulin (IM)

Revenue, means the sales value of Human Rabies Immunoglobulin (IM)

This report studies sales (consumption) of Human Rabies Immunoglobulin (IM) in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Baxter
• CSL
• Bayer
• Grifols
• Octapharma
• Shanghai RAAS
• Hualan Biological
• China Biologic
• Shuanglin Bio-pharmacy
• Sichuan Yuanda Shuyang
• Boya Bio-pharmaceutical

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• 100IU（1.0ml)/Vial
• 200IU（2.0ml)/Vial
• 500IU（5.0ml)/Vial

Split by applications, this report focuses on sales, market share and growth rate of Human Rabies Immunoglobulin (IM) in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Human Rabies Immunoglobulin (IM) Market Report 2016

1 HUMAN RABIES IMMUNOGLOBULIN (IM) OVERVIEW

1.1 Product Overview and Scope of Human Rabies Immunoglobulin (IM)
1.2 Classification of Human Rabies Immunoglobulin (IM)
  1.2.1 100IU（1.0ml)/Vial
  1.2.2 200IU（2.0ml)/Vial
  1.2.3 500IU（5.0ml)/Vial
1.3 Application of Human Rabies Immunoglobulin (IM)
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Human Rabies Immunoglobulin (IM) (2011-2021)
  1.4.1 United States Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2011-2021)
  1.4.2 United States Human Rabies Immunoglobulin (IM) Revenue and Growth Rate (2011-2021)

2 UNITED STATES HUMAN RABIES IMMUNOGLOBULIN (IM) COMPETITION BY MANUFACTURERS

2.1 United States Human Rabies Immunoglobulin (IM) Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Human Rabies Immunoglobulin (IM) Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Human Rabies Immunoglobulin (IM) Average Price by Manufactures (2015 and 2016)
2.4 Human Rabies Immunoglobulin (IM) Market Competitive Situation and Trends
  2.4.1 Human Rabies Immunoglobulin (IM) Market Concentration Rate
  2.4.2 Human Rabies Immunoglobulin (IM) Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES HUMAN RABIES IMMUNOGLOBULIN (IM) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Human Rabies Immunoglobulin (IM) Sales and Market Share by Type (2011-2016)
3.2 United States Human Rabies Immunoglobulin (IM) Revenue and Market Share by Type (2011-2016)
3.3 United States Human Rabies Immunoglobulin (IM) Price by Type (2011-2016)
3.4 United States Human Rabies Immunoglobulin (IM) Sales Growth Rate by Type (2011-2016)

4 UNITED STATES HUMAN RABIES IMMUNOGLOBULIN (IM) SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Human Rabies Immunoglobulin (IM) Sales and Market Share by Application (2011-2016)
4.2 United States Human Rabies Immunoglobulin (IM) Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES HUMAN RABIES IMMUNOGLOBULIN (IM) MANUFACTURERS PROFILES/ANALYSIS

5.1 Baxter
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Human Rabies Immunoglobulin (IM) Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Baxter Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 CSL
  5.2.2 Human Rabies Immunoglobulin (IM) Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 CSL Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Bayer
  5.3.2 Human Rabies Immunoglobulin (IM) Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Bayer Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Grifols
  5.4.2 Human Rabies Immunoglobulin (IM) Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Octapharma
  5.5.2 Human Rabies Immunoglobulin (IM) Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Octapharma Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Shanghai RAAS
  5.6.2 Human Rabies Immunoglobulin (IM) Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Hualan Biological
  5.7.2 Human Rabies Immunoglobulin (IM) Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Hualan Biological Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 China Biologic
  5.8.2 Human Rabies Immunoglobulin (IM) Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 China Biologic Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Shuanglin Bio-pharmacy
  5.9.2 Human Rabies Immunoglobulin (IM) Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Shuanglin Bio-pharmacy Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Sichuan Yuanda Shuyang
  5.10.2 Human Rabies Immunoglobulin (IM) Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Boya Bio-pharmaceutical

6 HUMAN RABIES IMMUNOGLOBULIN (IM) MANUFACTURING COST ANALYSIS

6.1 Human Rabies Immunoglobulin (IM) Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Human Rabies Immunoglobulin (IM) Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Human Rabies Immunoglobulin (IM) Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES HUMAN RABIES IMMUNOGLOBULIN (IM) MARKET FORECAST (2016-2021)

10.1 United States Human Rabies Immunoglobulin (IM) Sales, Revenue Forecast (2016-2021)
10.2 United States Human Rabies Immunoglobulin (IM) Sales Forecast by Type (2016-2021)
10.3 United States Human Rabies Immunoglobulin (IM) Sales Forecast by Application (2016-2021)
10.4 Human Rabies Immunoglobulin (IM) Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Human Rabies Immunoglobulin (IM)
Table Classification of Human Rabies Immunoglobulin (IM)
Figure United States Sales Market Share of Human Rabies Immunoglobulin (IM) by Type in 2015
Figure 100IU（1.0ml)/Vial Picture
Figure 200IU（2.0ml)/Vial Picture
Figure 500IU（5.0ml)/Vial Picture
Table Application of Human Rabies Immunoglobulin (IM)
Figure United States Sales Market Share of Human Rabies Immunoglobulin (IM) by Application in 2015
Figure United States Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2011-2021)
Figure United States Human Rabies Immunoglobulin (IM) Revenue and Growth Rate (2011-2021)
Table United States Human Rabies Immunoglobulin (IM) Sales of Key Manufacturers (2015 and 2016)
Table United States Human Rabies Immunoglobulin (IM) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Human Rabies Immunoglobulin (IM) Sales Share by Manufacturers
Figure 2016 Human Rabies Immunoglobulin (IM) Sales Share by Manufacturers
Table United States Human Rabies Immunoglobulin (IM) Revenue by Manufacturers (2015 and 2016)
Table United States Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturers
Table 2016 United States Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturers
Table United States Market Human Rabies Immunoglobulin (IM) Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Human Rabies Immunoglobulin (IM) Average Price of Key Manufacturers in 2015
Figure Human Rabies Immunoglobulin (IM) Market Share of Top 3 Manufacturers
Figure Human Rabies Immunoglobulin (IM) Market Share of Top 5 Manufacturers
Table United States Human Rabies Immunoglobulin (IM) Sales by Type (2011-2016)
Table United States Human Rabies Immunoglobulin (IM) Sales Share by Type (2011-2016)
Figure United States Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2015
Table United States Human Rabies Immunoglobulin (IM) Revenue and Market Share by Type (2011-2016)
Table United States Human Rabies Immunoglobulin (IM) Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Human Rabies Immunoglobulin (IM) by Type (2011-2016)
Table United States Human Rabies Immunoglobulin (IM) Price by Type (2011-2016)
Figure United States Human Rabies Immunoglobulin (IM) Sales Growth Rate by Type (2011-2016)
Table United States Human Rabies Immunoglobulin (IM) Sales by Application (2011-2016)
Table United States Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2011-2016)
Figure United States Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2015
Table United States Human Rabies Immunoglobulin (IM) Sales Growth Rate by Application (2011-2016)
Figure United States Human Rabies Immunoglobulin (IM) Sales Growth Rate by Application (2011-2016)
Table Baxter Basic Information List
Table Baxter Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Baxter Human Rabies Immunoglobulin (IM) Sales Market Share (2011-2016)
Table CSL Basic Information List
Table CSL Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table CSL Human Rabies Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Human Rabies Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Grifols Basic Information List
Table Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Grifols Human Rabies Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Octapharma Basic Information List
Table Octapharma Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Octapharma Human Rabies Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Shanghai RAAS Basic Information List
Table Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Hualan Biological Basic Information List
Table Hualan Biological Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hualan Biological Human Rabies Immunoglobulin (IM) Sales Market Share (2011-2016)
Table China Biologic Basic Information List
Table China Biologic Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table China Biologic Human Rabies Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Shuanglin Bio-pharmacy Basic Information List
Table Shuanglin Bio-pharmacy Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shuanglin Bio-pharmacy Human Rabies Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Sichuan Yuanda Shuyang Basic Information List
Table Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Boya Bio-pharmaceutical Basic Information List
Table Boya Bio-pharmaceutical Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boya Bio-pharmaceutical Human Rabies Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Rabies Immunoglobulin (IM)
Figure Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
Figure Human Rabies Immunoglobulin (IM) Industrial Chain Analysis
Table Raw Materials Sources of Human Rabies Immunoglobulin (IM) Major Manufacturers in 2015
Table Major Buyers of Human Rabies Immunoglobulin (IM)
Table Distributors/Traders List
Figure United States Human Rabies Immunoglobulin (IM) Production and Growth Rate Forecast (2016-2021)
Figure United States Human Rabies Immunoglobulin (IM) Revenue and Growth Rate Forecast (2016-2021)
Table United States Human Rabies Immunoglobulin (IM) Production Forecast by Type (2016-2021)
Table United States Human Rabies Immunoglobulin (IM) Consumption Forecast by Application (2016-2021)